Literature DB >> 24990740

Immunology: Fixing the odds against tuberculosis.

Samuel M Behar1, Christopher M Sassetti2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24990740     DOI： 10.1038/nature13512

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  13 in total

1.  Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis.

Authors:  Maziar Divangahi; Danielle Desjardins; Cláudio Nunes-Alves; Heinz G Remold; Samuel M Behar
Journal:  Nat Immunol       Date:  2010-07-11       Impact factor: 25.606

2.  Nitric oxide controls the immunopathology of tuberculosis by inhibiting NLRP3 inflammasome-dependent processing of IL-1β.

Authors:  Bibhuti B Mishra; Vijay A K Rathinam; Gregory W Martens; Amanda J Martinot; Hardy Kornfeld; Katherine A Fitzgerald; Christopher M Sassetti
Journal:  Nat Immunol       Date:  2012-11-18       Impact factor: 25.606

3.  Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population.

Authors:  Lis R V Antonelli; Antonio Gigliotti Rothfuchs; Ricardo Gonçalves; Ester Roffê; Allen W Cheever; Andre Bafica; Andres M Salazar; Carl G Feng; Alan Sher
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans.

Authors:  David M Tobin; Jay C Vary; John P Ray; Gregory S Walsh; Sarah J Dunstan; Nguyen D Bang; Deanna A Hagge; Saraswoti Khadge; Mary-Claire King; Thomas R Hawn; Cecilia B Moens; Lalita Ramakrishnan
Journal:  Cell       Date:  2010-03-05       Impact factor: 41.582

5.  Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo.

Authors:  Katrin D Mayer-Barber; Daniel L Barber; Kevin Shenderov; Sandra D White; Mark S Wilson; Allen Cheever; David Kugler; Sara Hieny; Patricia Caspar; Gabriel Núñez; Dirk Schlueter; Richard A Flavell; Fayyaz S Sutterwala; Alan Sher
Journal:  J Immunol       Date:  2010-03-03       Impact factor: 5.422

6.  The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.

Authors:  Diane Ordway; Marcela Henao-Tamayo; Marisa Harton; Gopinath Palanisamy; Jolynn Troudt; Crystal Shanley; Randall J Basaraba; Ian M Orme
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

7.  Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair.

Authors:  Maziar Divangahi; Minjian Chen; Huixian Gan; Danielle Desjardins; Tyler T Hickman; David M Lee; Sarah Fortune; Samuel M Behar; Heinz G Remold
Journal:  Nat Immunol       Date:  2009-06-28       Impact factor: 25.606

8.  Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Sandra D Oland; Eduardo P Amaral; Daniel L Barber; Jacqueline Gonzales; Steven C Derrick; Ruiru Shi; Nathella Pavan Kumar; Wang Wei; Xing Yuan; Guolong Zhang; Ying Cai; Subash Babu; Marta Catalfamo; Andres M Salazar; Laura E Via; Clifton E Barry; Alan Sher
Journal:  Nature       Date:  2014-06-25       Impact factor: 49.962

9.  An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis.

Authors:  Matthew P R Berry; Christine M Graham; Finlay W McNab; Zhaohui Xu; Susannah A A Bloch; Tolu Oni; Katalin A Wilkinson; Romain Banchereau; Jason Skinner; Robert J Wilkinson; Charles Quinn; Derek Blankenship; Ranju Dhawan; John J Cush; Asuncion Mejias; Octavio Ramilo; Onn M Kon; Virginia Pascual; Jacques Banchereau; Damien Chaussabel; Anne O'Garra
Journal:  Nature       Date:  2010-08-19       Impact factor: 49.962

10.  Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing.

Authors:  Philana Ling Lin; Christopher B Ford; M Teresa Coleman; Amy J Myers; Richa Gawande; Thomas Ioerger; James Sacchettini; Sarah M Fortune; JoAnne L Flynn
Journal:  Nat Med       Date:  2013-12-15       Impact factor: 53.440
View more
  2 in total

Review 1.  MyD88 in Mycobacterium tuberculosis infection.

Authors:  Jorge L Cervantes
Journal:  Med Microbiol Immunol       Date:  2017-02-20       Impact factor: 3.402

2.  Ifnar gene variants influence gut microbial production of palmitoleic acid and host immune responses to tuberculosis.

Authors:  Lingming Chen; Guoliang Zhang; Guobao Li; Wei Wang; Zhenhuang Ge; Yi Yang; Xing He; Zhi Liu; Zhiyi Zhang; Qiongdan Mai; Yiwei Chen; Zixu Chen; Jiang Pi; Shuai Yang; Jun Cui; Haipeng Liu; Ling Shen; Lingchan Zeng; Lin Zhou; Xinchun Chen; Baoxue Ge; Zheng W Chen; Gucheng Zeng
Journal:  Nat Metab       Date:  2022-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.